Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGs Chain Regulatory News (GSC)

  • This share is currently suspended. It was suspended at a price of 0.25

Share Price Information for Gs Chain (GSC)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.12m
GSC Live PriceLast checked at - London Stock Exchange

Intraday Gs Chain Share Chart

Director Resignation

22 May 2026 10:59

RNS Number : 4818F
GS Chain PLC
22 May 2026
 

GS CHAIN PLC("GS Chain" or the "Company")

 

Director Resignation

 

GS Chain Plc, a UK company admitted to the Equity Shares (Shell Companies) category of the Official List of the Financial Conduct Authority (the "Official List") and to the main market of the London Stock Exchange Group Plc ("Main Market"), announces that Mr. Mark Wilson has resigned as an Independent Non-Executive Director of the Company with immediate effect to pursue other professional opportunities.

 

The Board would like to thank Mark for his contribution to the Company and wishes him well in his future endeavours.

 

- Ends -

 

For further information please contact:

 

Paul Carroll, Director

paul@gschain.world

Bowsprit Partners Limited, Financial Adviser

John Treacy / Luis Brime

+44 (0)203 883 4430

 

Caution regarding forward looking statement:

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward-looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKBBPCBKKPPB
Date   Source Headline
22nd May 202610:59 amRNSDirector Resignation
8th May 20262:33 pmRNSInterim Results - 31 December 2025
24th Apr 20267:00 amRNSDirector Resignation and Appointment of Chairman
14th Apr 20268:00 amRNSAllotment and Admission of New Shares
4th Mar 20262:26 pmRNSResult of AGM
4th Mar 20267:30 amRNSConvertible Investment Agreement
17th Feb 20267:39 amRNSProposed Acquisition and Suspension of Trading
9th Feb 20267:00 amRNSDirector Appointment
6th Feb 20267:00 amRNSFurther re: Notice of AGM
3rd Feb 202611:00 amRNSNotice of AGM
8th Dec 20254:45 pmRNSCorporate Update
17th Nov 20252:49 pmRNSDirector/PDMR Shareholding
31st Oct 20256:05 pmRNSAudited Results
16th Oct 20259:16 amRNSConvertible Investment Agreement
3rd Sep 20253:57 pmRNSUpdate to Listing Rules for Shell Companies
31st Mar 20257:00 amRNSInterim Results - 31 December 2024
4th Mar 20257:00 amRNSBoard Change
24th Jan 20257:00 amRNSBoard Change and Change of Adviser
17th Dec 20244:21 pmRNSResults of Annual General Meeting
31st Oct 202412:02 pmRNSAudited Results And Notice of AGM
2nd Sep 202410:44 amRNSDelisting from the US OTCQB Market
28th Mar 20247:00 amRNSHalf-Year Results
7th Dec 202311:34 amRNSResults of Annual General Meeting
8th Nov 20235:00 pmRNSNotice of Annual General Meeting
31st Oct 20233:02 pmRNSAudited Results
11th Apr 20231:48 pmRNSCommencement of Trading on US OTCQB Venture Market
31st Mar 20237:00 amRNSHalf-Year Results
16th Dec 20224:28 pmRNSResults of Annual General Meeting 2022
23rd Nov 202212:26 pmRNSNotice of Annual General Meeting
9th Nov 20221:30 pmRNSIntention to Cross-Trade on OTC Markets Group
31st Oct 20221:02 pmRNSAudited Results
3rd Oct 20229:31 amRNSChange in Accounting Reference Date
13th May 20228:00 amRNSAdmission to trading and first day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.